Corvidia Therapeutics - Ownership and Business Overview

Life ScienceCompany

Corvidia Therapeutics Ownership

Who owns Corvidia Therapeutics?

Corvidia Therapeutics is owned by Novo Nordisk A/S. It was acquired on June 11, 2020.

Corvidia Therapeutics Business Overview

Where is Corvidia Therapeutics headquartered?

Corvidia Therapeutics is headquartered in Waltham, Massachusetts.

What sector is Corvidia Therapeutics in?

Corvidia Therapeutics is a life science company.

When was Corvidia Therapeutics founded?

Corvidia Therapeutics was founded in 2015.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 282 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 259 by strategics.

Corvidia Therapeutics, Inc.

35 Gatehouse Drive,
Waltham, Massachusetts 02451
United States,
(781) 205-4755
www.corvidiatx.com

Corvidia Therapeutics, Inc. is a clinical-stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis. Corvidia Therapeutics was founded in 2015 and is headquartered in Waltham, Massachusetts.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.